Patents by Inventor Takanori Takebe
Takanori Takebe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240125767Abstract: The present invention provides drug toxicity evaluation platforms (such as an evaluation method and a kit therefor) that enable detailed analysis of the possibility and the like of developing drug-induced damage (such as DILI) to the liver and other organs. The method for evaluating drug toxicity of the present invention includes: a step of adding a drug to a co-culture system of an organoid and blood cells; and a step of evaluating the toxicity of the drug to the organoid.Type: ApplicationFiled: October 16, 2020Publication date: April 18, 2024Applicants: Public University Corporation Yokohama City University, Takeda Pharmaceutical Company LimitedInventors: Takanori TAKEBE, Norikazu SAIKI
-
Publication number: 20240093134Abstract: Provided is a culture chamber capable of preparing spheroids with a uniform size with high efficiency and having a micro-space structure which is designed to facilitate replacement of a medium and harvesting of cells. The culture chamber includes a plurality of recesses (10) each formed of a bottom portion (11) and an opening portion (12). The bottom portion (11) has one of a hemispherical shape and a truncated cone shape and the opening portion (12) is defined by a wall that surrounds an area from a boundary between the opening portion (12) and the bottom portion (11) to an end of each of the recesses (10), the wall having a taper angle in a range from 1 degree to 20 degrees. An equivalent diameter of the boundary is in a range from 50 ?m to 2 mm and a depth from a bottom of the bottom portion (11) to the end of each of the recesses is in a range from 0.Type: ApplicationFiled: November 28, 2023Publication date: March 21, 2024Inventors: Yoko Ejiri, Satoru Ayano, Naoto Fukuhara, Hideki Taniguchi, Takanori Takebe
-
Patent number: 11866682Abstract: Provided is a culture chamber that includes a plurality of recesses each formed of a bottom portion and an opening portion. The bottom portion has a hemispherical shape or a truncated cone shape. The opening portion is defined by a wall that surrounds an area from a boundary between the opening portion and the bottom portion to an end of each of the recesses, the wall having a taper angle in a range from 1 to 20 degrees. An equivalent diameter of the boundary is from 50 ?m to 2 mm and a depth from a bottom of the bottom portion to the end of each of the recesses is from 0.6 or more times to 3 or less times the equivalent diameter, and the wall defining the opening portion forms a surface continuous to the bottom portion. An inclination of the continuous surface changes at the boundary.Type: GrantFiled: September 30, 2022Date of Patent: January 9, 2024Assignee: CORNING INCORPORATEDInventors: Yoko Ejiri, Satoru Ayano, Naoto Fukuhara, Hideki Taniguchi, Takanori Takebe
-
Publication number: 20230384291Abstract: The present invention provides means for producing a parathyroid gland organoid. A culture method of the present invention includes a cell population containing a parathyroid gland cell in a ratio of 50% or more, and a mesenchymal cell in a ratio of 10% or more; and a step of culturing the cell population.Type: ApplicationFiled: September 28, 2021Publication date: November 30, 2023Applicants: National University Corporation Tokyo Medical and Dental University, Takeda Pharmaceutical Company LimitedInventors: Takanori TAKEBE, Norikazu SAIKI
-
Publication number: 20230235316Abstract: Disclosed herein are insulin resistance reporters for use in quantifying insulin response in biological cells. These biological cells may be stem cell compositions or derivatives thereof comprising the insulin resistance reporter. The stem cell derivatives include but are not limited to insulin responsive cells, tissues, or organoids, such as pancreatic, brain, adipose, muscle, or liver cells, or tissues or organoids thereof. Also disclosed herein are methods of using said insulin resistance reporters and cells with these insulin resistance reporters as models to examine insulin resistance and screening for compounds that are potentially useful for the treatment of diseases or disorders associated with insulin resistance. The cells comprising an insulin resistance reporter may be hepatic cells or liver organoid compositions, which can be used in investigating hepatic insulin resistance, for example, as a result of non-alcoholic fatty liver disease or steatohepatitis.Type: ApplicationFiled: June 22, 2021Publication date: July 27, 2023Inventors: Takanori Takebe, Masaki Kimura
-
Publication number: 20230212492Abstract: The present invention provides a culture method capable of maturing an organoid through long-term culture, and suitable for producing a conformational organ. The culture method of the present invention is a method for culturing an organoid and/or cells constituting an organ immobilized in a chamber with a culture fluid perfused, and the culture fluid is perfused in such a manner as to generate a turbulent flow in the chamber.Type: ApplicationFiled: June 7, 2021Publication date: July 6, 2023Applicants: National University Corporation Tokyo Medical and Dental University, Takeda Pharmaceutical Company LimitedInventors: Takanori TAKEBE, Norikazu SAIKI
-
Publication number: 20230191096Abstract: A pharmaceutical composition may be used in administering oxygen to a subject. The pharmaceutical composition may contain a perfluorocarbon dissolving oxygen therein. Further, a pharmaceutical composition may be used in decreasing the blood carbon dioxide partial pressure of a subject, and the pharmaceutical composition may contain a perfluorocarbon. Such a composition may be suitable for administered oral administration, nasogastric administration, trans-fistula gastric administration, or administration into a large intestine.Type: ApplicationFiled: May 13, 2021Publication date: June 22, 2023Applicant: National University Corporation Tokyo Medical and Dental UniversityInventors: Takanori TAKEBE, Yosuke YONEYAMA, Ryo OKABE, Toyofumi YOSHIKAWA, Hiroshi DATE
-
Publication number: 20230154003Abstract: A cell evaluation method includes acquiring a first evaluation index and a first index calculated using the first evaluation index with respect to comparative target cells in a culture process including a cell differentiation-inducing process in which cell differentiation is induced, calculating a second index on the basis of the first evaluation index with respect to evaluation target cells different from the comparative target cells, and evaluating differentiation of the evaluation target cells by comparing the first index with the second index.Type: ApplicationFiled: November 2, 2020Publication date: May 18, 2023Inventors: Hideki TANIGUCHI, Takanori TAKEBE, Momotaro ISHIKAWA, Masafumi YAMASHITA, Yasujiro KIYOTA
-
Patent number: 11603520Abstract: The present invention provides a method of constituting a tissue construct in vitro using a tissue without depending on scaffold materials. A method of integrating a biological tissue with a vascular system in vitro, comprising coculturing a biological tissue with vascular cells and mesenchymal cells. A biological tissue which has been integrated with a vascular system by the above-described method. A method of preparing a tissue or an organ, comprising transplanting the biological tissue described above into a non-human animal and differentiating the biological tissue into a tissue or an organ in which vascular networks have been constructed. A method of regeneration or function recovery of a tissue or an organ, comprising transplanting the biological tissue described above into a human or a non-human animal and differentiating the biological tissue into a tissue or an organ in which vascular networks have been constructed.Type: GrantFiled: June 11, 2021Date of Patent: March 14, 2023Assignee: Public University Corporation Yokohama City UniversityInventors: Takanori Takebe, Hideki Taniguchi, Yoshinobu Takahashi
-
Patent number: 11473046Abstract: Provided is a culture chamber that includes a plurality of recesses each formed of a bottom portion and an opening portion. The bottom portion has a hemispherical shape or a truncated cone shape. The opening portion is defined by a wall that surrounds an area from a boundary between the opening portion and the bottom portion to an end of each of the recesses, the wall having a taper angle in a range from 1 to 20 degrees. An equivalent diameter of the boundary is from 50 ?m to 2 mm and a depth from a bottom of the bottom portion to the end of each of the recesses is from 0.6 or more times to 3 or less times the equivalent diameter, and the wall defining the opening portion forms a surface continuous to the bottom portion. An inclination of the continuous surface changes at the boundary.Type: GrantFiled: October 30, 2019Date of Patent: October 18, 2022Assignee: CORNING INCORPORATEDInventors: Yoko Ejiri, Satoru Ayano, Naoto Fukuhara, Hideki Taniguchi, Takanori Takebe
-
Publication number: 20220252575Abstract: A method for screening for a therapeutic drug for a disease involving excessive activation of a complement, using a s cytotoxicity marker associated with the complement as an index, including (1a) a step of adding a complement to a cell produced from a stem cell to cause the cell to form a cytotoxicity marker associated with the complement, and (2a) a step of adding a therapeutic drug candidate, and selecting a substance that decreases the amount of the cytotoxicity marker is provided by the present invention.Type: ApplicationFiled: March 27, 2020Publication date: August 11, 2022Applicants: Public University Corporation Yokohama City University, Takeda Pharmaceutical Company LimitedInventors: Takanori TAKEBE, Norikazu SAIKI, Yasunori NIO, Eri KAWAKAMI
-
Publication number: 20220228211Abstract: Existing single cell analysis techniques are generally high-resolution but are limited in the number of possible different experimental conditions. Disclosed herein are compositions and methods for multiplexed barcoding of a heterogenous population of cells using cationic polymers for delivery of nucleic acid barcodes to a cell population.Type: ApplicationFiled: May 29, 2020Publication date: July 21, 2022Inventors: Takanori Takebe, Andrew Dunn
-
Publication number: 20220220444Abstract: Production and maintenance of hematopoietic stem cells in in vitro culture systems has proven to be elusive. Disclosed herein are hematopoietic stem cell compositions that originate from organoids such as liver organoids. These organoids also comprise a rare type of immune cell that is not yet fully elucidated due to the difficulty in isolating said immune cell from biological samples. Also disclosed herein are methods of producing said hematopoietic stem cells and immune cells from organoids, as well as methods of expanding hematopoietic stem cells from other sources using these organoids.Type: ApplicationFiled: May 29, 2020Publication date: July 14, 2022Inventors: Takanori Takebe, Kyle Lewis
-
Publication number: 20220213444Abstract: Disclosed herein are compositions and methods for re-programming induced pluripotent stem cells, such as from a primed to naïve state. Further disclosed herein are methods of making said reprogrammed induced pluripotent stem cells by contacting the stem cells with another population of stem cells.Type: ApplicationFiled: May 29, 2020Publication date: July 7, 2022Inventor: Takanori Takebe
-
Publication number: 20220195367Abstract: The present invention provides means for producing an organoid close to an organ in a living body and capable of secretion of a plasma protein and immune response. A matrix composition of the present invention provided as such means includes: (1) a first matrix containing one or more cells selected from the group consisting of vascular cells, nerve cells, and blood cells; and (2) a second matrix containing to cells constituting an organ and/or an organoid, in which the first matrix envelops the second matrix, and the first matrix has at least one opening.Type: ApplicationFiled: March 27, 2020Publication date: June 23, 2022Applicants: Public University Corporation Yokohama City University, Takeda Pharmaceutical Company LimitedInventors: Takanori TAKEBE, Norikazu SAIKI
-
Publication number: 20220167597Abstract: The present invention provides a method of constituting a tissue construct in vitro using a tissue without depending on scaffold materials. A method of integrating a biological tissue with a vascular system in vitro, comprising coculturing a biological tissue with vascular cells and mesenchymal cells. A biological tissue which has been integrated with a vascular system by the above-described method. A method of preparing a tissue or an organ, comprising transplanting the biological tissue described above into a non-human animal and differentiating the biological tissue into a tissue or an organ in which vascular networks have been constructed. A method of regeneration or function recovery of a tissue or an organ, comprising transplanting the biological tissue described above into a human or a non-human animal and differentiating the biological tissue into a tissue or an organ in which vascular networks have been constructed.Type: ApplicationFiled: June 11, 2021Publication date: June 2, 2022Applicant: Public University Corporation Yokohama City UniversityInventors: Takanori Takebe, Hideki Taniguchi, Yoshinobu Takahashi
-
Patent number: 11326150Abstract: The present invention provides a means for reconstituting tissues and organs having mature functions. A method of preparing a tissue or an organ, comprising coculturing an organ cell with a vascular endothelial cell and a mesenchymal cell, generating an organ bud, transplanting the organ bud into a non-human animal, and then isolating from the non-human animal the transplanted organ bud-derived tissue or organ.Type: GrantFiled: September 27, 2012Date of Patent: May 10, 2022Assignee: Public University Corporation Yokohama City UniversityInventors: Hideki Taniguchi, Takanori Takebe
-
Publication number: 20220135938Abstract: The present invention provides a means for suppressing formation and/or proliferation of undesired cells derived from stem cells in a cell population containing cells differentiated from stem cells. The nutrition composition according to the present invention is a nutrition composition for suppressing formation and/or proliferation of undesired cells derived from stem cells in a cell population containing cells differentiated from stem cells, the nutrition composition containing at least one essential amino acid selected from the group consisting of isoleucine, leucine, methionine, lysine, phenylalanine, tryptophan, threonine and histidine except valine, and optionally containing a non-essential amino acid(s).Type: ApplicationFiled: October 11, 2019Publication date: May 5, 2022Applicants: Public University Corporation Yokohama City University, Takeda Pharmaceutical Company LimitedInventors: Takanori TAKEBE, Yasunori NIO
-
Publication number: 20220088085Abstract: The present invention provides a composition suitable as a composition for treating blood coagulation and/or complement disorders (raw materials for producing therapeutic agents for these diseases) and a method for effectively producing the composition. A method for producing a composition for treating blood coagulation and/or complement disorders according to the present invention includes the following steps of: (1) embedding an organoid formed from vascular endothelial cells or vascular endothelial cells and hepatocytes, in an extracellular matrix; (2) culturing the extracellular matrix; and (3) collecting a culture supernatant from the culture obtained in the step (2).Type: ApplicationFiled: February 27, 2020Publication date: March 24, 2022Applicants: Public University Corporation Yokohama City University, Takeda Pharmaceutical Company LimitedInventors: Takanori TAKEBE, Norikazu SAIKI, Eri KAWAKAMI
-
Patent number: 11186810Abstract: A cell culture container includes a storage container, a cell culture area, a culture solution supply unit, and a discharge unit. The cell culture area is a region for culturing cells, and is provided in the storage container. The culture solution supply unit supplies the culture solution into the cell culture area at a flow rate equal to or less than a predetermined flow rate. The discharge unit discharges the liquid in the cell culture area to the outside of the storage container. A rectification unit is a structure in which a plurality of outflow ports are uniformly arranged in a direction perpendicular to the flow direction of the culture solution from the culture solution supply unit to the discharge unit.Type: GrantFiled: March 16, 2016Date of Patent: November 30, 2021Assignees: SHIMADZU CORPORATION, YOKOHAMA CITY UNIVERSITY, OSAKA UNIVERSITY, CORNING INCORPORATEDInventors: Tomoki Ohkubo, Masaki Kanai, Hirohisa Abe, Hideki Taniguchi, Masahiro Kinooka, Goro Kobayashi, Takanori Takebe